Singular Genomics Systems, Inc. (OMIC)
USD 20.01
(0.0%)
USD 20.01
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 59.05 Million USD | 482.93% |
| 2022 | -15.42 Million USD | 91.93% |
| 2021 | -191.14 Million USD | -8236.02% |
| 2020 | -2.29 Million USD | 26.03% |
| 2019 | -3.1 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 49.43 Million USD | -16.29% |
| 2024 Q2 | 45.61 Million USD | -15.69% |
| 2023 FY | 59.05 Million USD | 482.93% |
| 2023 Q3 | 43.7 Million USD | 366.1% |
| 2023 Q2 | -16.42 Million USD | 76.76% |
| 2023 Q4 | 59.05 Million USD | 35.12% |
| 2023 Q1 | -70.67 Million USD | -358.29% |
| 2022 Q3 | -34.21 Million USD | 63.41% |
| 2022 Q1 | -172.1 Million USD | 9.96% |
| 2022 FY | -15.42 Million USD | 91.93% |
| 2022 Q4 | -15.42 Million USD | 54.92% |
| 2022 Q2 | -93.49 Million USD | 45.68% |
| 2021 Q4 | -191.14 Million USD | 16.67% |
| 2021 Q3 | -229.39 Million USD | 7.39% |
| 2021 Q2 | -247.71 Million USD | -334.03% |
| 2021 FY | -191.14 Million USD | -8236.02% |
| 2021 Q1 | 105.84 Million USD | 4716.09% |
| 2020 Q4 | -2.29 Million USD | 0.0% |
| 2020 FY | -2.29 Million USD | 26.03% |
| 2020 Q1 | 46.19 Million USD | 0.0% |
| 2019 FY | -3.1 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | -2188.067% |
| AngioDynamics, Inc. | -70.14 Million USD | 184.193% |
| AtriCure, Inc. | -9.81 Million USD | 701.62% |
| Avinger, Inc. | 10.12 Million USD | -483.547% |
| Azenta, Inc. | -618.47 Million USD | 109.549% |
| BioLife Solutions, Inc. | 7.25 Million USD | -714.215% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 97.588% |
| Daxor Corporation | 755.65 Thousand USD | -7715.033% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | 4117.347% |
| Femasys Inc. | -15.01 Million USD | 493.302% |
| GlucoTrack, Inc. | -4.29 Million USD | 1474.651% |
| Harvard Bioscience, Inc. | 38.49 Million USD | -53.429% |
| Hologic, Inc. | 374.4 Million USD | 84.227% |
| ICU Medical, Inc. | 1.45 Billion USD | 95.929% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 102.22% |
| KORU Medical Systems, Inc. | -7.03 Million USD | 939.193% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | 1241.38% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 1477.393% |
| Innovative Eyewear, Inc. | -4.28 Million USD | 1477.393% |
| Masimo Corporation | 804 Million USD | 92.655% |
| Microbot Medical Inc. | -2.28 Million USD | 2683.333% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 715.429% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 80.46% |
| Nephros, Inc. | -2.47 Million USD | 2489.923% |
| NovoCure Limited | 355.42 Million USD | 83.384% |
| NEXGEL, Inc. | 98 Thousand USD | -60160.204% |
| NEXGEL, Inc. | 98 Thousand USD | -60160.204% |
| OraSure Technologies, Inc. | -276.9 Million USD | 121.327% |
| Pro-Dex, Inc. | 10.91 Million USD | -440.995% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 267.67% |
| Predictive Oncology Inc. | -5.87 Million USD | 1105.731% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | -1849.536% |
| QuidelOrtho Corporation | 2.49 Billion USD | 97.633% |
| Repligen Corporation | -39.51 Million USD | 249.434% |
| Sanara MedTech Inc. | 6.64 Million USD | -788.727% |
| STAAR Surgical Company | -147.2 Million USD | 140.118% |
| Sharps Technology, Inc. | -3.01 Million USD | 2060.066% |
| Utah Medical Products, Inc. | -92.52 Million USD | 163.825% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 96.995% |
| Jin Medical International Ltd. | -2.81 Million USD | 2196.745% |